CNMD - Company ID 0000816956
The table below shows CONMED Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|
| Operating cash flow | $29.12M | -$3.85M | $328.00K | $22.34M | $3.72M | -$3.92M |
| Capital expenditure | $2.04M | $4.25M | $3.69M | $3.11M | $2.83M | $4.02M |
| Investing cash flow | -$2.04M | -$4.25M | -$3.69M | -$3.11M | -$6.68M | -$368.95M |
| Dividends paid | $6.15M | $6.10M | $5.87M |
CONMED Corp reported operating cash flow of $170.69M for fiscal year 2025. That is up 2.2% from $166.97M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $39.88M (FY 2016) to $170.69M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $5.78M |
| $5.68M |
| $5.63M |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$17.01M | $5.35M | $7.49M | -$8.87M | $2.74M | $378.95M |